Meiragtx, Llc
Clinical trials sponsored by Meiragtx, Llc, explained in plain language.
-
Gene therapy trial hopes to restore saliva for cancer survivors
Disease control OngoingThis early-stage trial tests a new gene therapy for people with chronic dry mouth after radiation for head and neck cancer. The treatment delivers a gene directly into a saliva gland to help it produce more saliva. The main goal is to check safety in 17 adults, with a secondary l…
Phase: PHASE1 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Gene therapy for radiation dry mouth: long-term follow-up begins
Disease control ENROLLING_BY_INVITATIONThis study follows 276 adults who received a gene therapy (AAV2-hAQP1) for dry mouth caused by past radiation for head and neck cancers. The goal is to see if the treatment remains safe and effective over time. Participants must have already received the therapy in an earlier stu…
Phase: PHASE2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated May 01, 2026 15:58 UTC